AirSculpt Technologies, Inc. (AIRS - Free Report) reported $47.61 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 17%. EPS of $0.01 for the same period compares to $0.07 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $47.83 million, representing a surprise of -0.46%. The company delivered an EPS surprise of -90.91%, with the consensus EPS estimate being $0.11.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how AirSculpt Technologies, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Number of total procedure rooms (end of the period): 57 versus the two-analyst average estimate of 27.
- Revenue per case: $12,937 compared to the $12,624.96 average estimate based on two analysts.
- Cases: 3,680 versus the two-analyst average estimate of 3,801.
View all Key Company Metrics for AirSculpt Technologies, Inc. here>>>Shares of AirSculpt Technologies, Inc. have returned -18.6% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Just Released: Zacks Top 10 Stocks for 2024
Hurry – you can still get in early on our 10 top tickers for 2024. Hand-picked by Zacks Director of Research, Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2024. You can still be among the first to see these just-released stocks with enormous potential.
See New Top 10 Stocks >>
AirSculpt Technologies, Inc. (AIRS - Free Report) reported $47.61 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 17%. EPS of $0.01 for the same period compares to $0.07 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $47.83 million, representing a surprise of -0.46%. The company delivered an EPS surprise of -90.91%, with the consensus EPS estimate being $0.11.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how AirSculpt Technologies, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Number of total procedure rooms (end of the period): 57 versus the two-analyst average estimate of 27.
- Revenue per case: $12,937 compared to the $12,624.96 average estimate based on two analysts.
- Cases: 3,680 versus the two-analyst average estimate of 3,801.
View all Key Company Metrics for AirSculpt Technologies, Inc. here>>>Shares of AirSculpt Technologies, Inc. have returned -18.6% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Just Released: Zacks Top 10 Stocks for 2024
Hurry – you can still get in early on our 10 top tickers for 2024. Hand-picked by Zacks Director of Research, Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2024. You can still be among the first to see these just-released stocks with enormous potential.
See New Top 10 Stocks >>
Get the latest research report on AIRS - FREE